Highline Capital Management
7
65M
5
0.24
0.29
2
- Stages of investment
- Areas of investment
Summary
Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. Among the most popular fund investment industries, there is Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Passage Bio.
The usual cause for the fund is to invest in rounds with more than 10 partakers. Despite the Highline Capital Management, startups are often financed by Vivo Capital, Versant Ventures, OrbiMed. The meaningful sponsors for the fund in investment in the same round are Logos Capital, Vivo Capital, Versant Ventures.
The top activity for fund was in 2019. The fund is generally included in less than 2 deals every year. Deals in the range of more than 100 millions dollars are the general things for fund.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.24
- Follow on index
- 0.29
- Investments by industry
- Biotechnology (6)
- Health Care (5)
- Therapeutics (3)
- Medical (3)
- Life Science (2) Show 7 more
- Investments by region
-
- United States (5)
- Germany (2)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Avg. valuation at time of investment
- 360M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Proscia | 13 Mar 2024 | Biotechnology, Software, Artificial Intelligence, Medical | Late Stage Venture | 9M | United States, Pennsylvania, Philadelphia |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.